Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REGORAFENIB vs RELPAX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REGORAFENIB vs RELPAX: Safety Overview

Metric REGORAFENIB RELPAX
Total FAERS Reports 9,441 135
Deaths Reported 1,869 1
Death Rate 19.8% 0.7%
Hospitalizations 3,363 11
Average Patient Age 62.2 yrs 47.4 yrs
% Female Patients 39.9% N/A
FDA Approval Date Jan 13, 2025 N/A
Manufacturer Bayer HealthCare Pharmaceuticals Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A